midostaurin
Showing 1 - 25 of 34
AML, Adult Trial in Berne (HDM201, Midostaurin)
Terminated
- AML, Adult
- HDM201
- Midostaurin
-
Berne, SwitzerlandDepartement of Medical Oncology, University Hospital Berne
Oct 3, 2022
FMS-Like Tyrosine Kinase 3-mutated Acute Myeloid Leukemia Trial (midostaurin)
Available
- FMS-Like Tyrosine Kinase 3-mutated Acute Myeloid Leukemia
- midostaurin
- (no location specified)
Oct 18, 2022
Core Binding Factor Acute Myeloid Leukemia (CBF-AML) Trial in Milano (Midostaurin)
Recruiting
- Core Binding Factor Acute Myeloid Leukemia (CBF-AML)
- Midostaurin
-
Milano, ItalyOspedale Cà Granda - Niguarda S.C: Ematologia
Jan 22, 2022
Acute Myeloid Leukemia Trial in Miami (CPX-351, Midostaurin, Busulfan)
Recruiting
- Acute Myeloid Leukemia
- CPX-351
- +5 more
-
Miami, FloridaMiami Cancer Institute at Baptist Health of South Florida
Jul 27, 2022
Healthcare Resource Utilization in Adults Diagnosed With Acute
Completed
- Acute Myeloid Leukemia (AML)
- Midostaurin
-
Helsinki, FinlandNovartis Investigative Site
Aug 3, 2022
Acute Myeloid Leukemia Trial in Worldwide (Midostaurin, Placebo)
Active, not recruiting
- Acute Myeloid Leukemia
- Midostaurin
- Placebo
-
Hong Kong, Hong Kong
- +40 more
Jan 20, 2023
Acute Myeloid Leukemia, Adult Trial in Germany (Midostaurin)
Terminated
- Acute Myeloid Leukemia, Adult
- Midostaurin
-
Chemnitz, Germany
- +3 more
Jan 20, 2022
Acute Myeloid Leukemia Trial in United States (Gilteritinib, Midostaurin, Daunorubicin)
Active, not recruiting
- Acute Myeloid Leukemia
- Gilteritinib
- +3 more
-
Scottsdale, Arizona
- +43 more
Nov 17, 2022
Hepatic Impairment Trial in Worldwide (Midostaurin)
Completed
- Hepatic Impairment
- Midostaurin
-
San Antonio, Texas
- +6 more
May 8, 2021
Acute Myeloid Leukemia Trial in United States (CPX-351, Venetoclax, Midostaurin)
Active, not recruiting
- Acute Myeloid Leukemia
- CPX-351
- +3 more
-
Duarte, California
- +9 more
Jan 3, 2023
Acute Myeloid Leukemia, Myelodysplastic Syndrome With Excess Blasts-2 Trial in Worldwide (Gilteritinib, Midostaurin)
Suspended
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome With Excess Blasts-2
- Gilteritinib
- Midostaurin
-
Adelaide, Australia
- +193 more
Jan 5, 2023
Acute Myeloid Leukemia Trial in Worldwide (Midostaurin)
Completed
- Acute Myeloid Leukemia
- Midostaurin
-
Pleven, Bulgaria
- +85 more
Feb 11, 2022
Acute Myeloid Leukemia (AML) Trial in Worldwide (Midostaurin, Midostaurin Placebo, Chemotherapy)
Terminated
- Acute Myeloid Leukemia (AML)
- Midostaurin
- +2 more
-
Chicago, Illinois
- +132 more
Jan 24, 2022
Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in
Recruiting
- Acute Biphenotypic Leukemia
- +13 more
- Cladribine
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Jan 19, 2023
Acute Myeloid Leukemia Trial in Canada, United States (Midostaurin, Standard of Care)
Completed
- Acute Myeloid Leukemia
- Midostaurin
- Standard of Care
-
La Jolla, California
- +18 more
Mar 12, 2021
Acute Myeloid Leukemia, Myelodysplastic Syndrome, Myelodysplastic Syndrome With Excess Blasts-2 Trial in United States (drug,
Active, not recruiting
- Acute Myeloid Leukemia
- +2 more
- Azacitidine
- +5 more
-
Anchorage, Alaska
- +506 more
Jan 28, 2023
Acute Myeloid Leukemia With FLT3/ITD Mutation Trial in Italy (Cytarabine, Daunorubicin, Midostaurin)
Recruiting
- Acute Myeloid Leukemia With FLT3/ITD Mutation
- Cytarabine
- +3 more
-
Bari, Italy
- +19 more
Mar 1, 2022
Acute Myeloid Leukemia (AML) Trial in Germany, United States (cytarabine, daunorubicin HCl, midostaurin)
Completed
- Acute Myeloid Leukemia (AML)
- cytarabine
- +2 more
-
Los Angeles, California
- +5 more
Dec 16, 2020
Newly Diagnosed FLT3 Mutated AML Trial in United States (Crenolanib, Midostaurin, Cytarabine)
Recruiting
- Newly Diagnosed FLT3 Mutated AML
- Crenolanib
- +3 more
-
Duarte, California
- +30 more
May 21, 2020
FLT3-mutated Acute Myeloid Leukemia Trial in Hamilton, Montreal (Midostaurin)
No longer available
- FLT3-mutated Acute Myeloid Leukemia
- Midostaurin
-
Hamilton, Ontario, Canada
- +1 more
Oct 14, 2019
Leukemia Trial in Canada, United States (cytarabine, daunorubicin, midostaurin)
Acute Myeloid Leukemia (AML) With, FLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD) Trial in
No longer available
- Acute Myeloid Leukemia (AML) With
- FLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD)
- Midostaurin
-
Phoenix, Arizona
- +43 more
Jul 14, 2020
Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Gene Mutations, FLT3 Tyrosine Kinase Domain Point
Terminated
- Acute Myeloid Leukemia With FLT3/ITD Mutation
- +4 more
- Decitabine
- +2 more
-
Rochester, MinnesotaMayo Clinic
Jul 17, 2019
Acute Myeloid Leukemia Trial in Austria, Germany (Midostaurin, Cytarabine, Daunorubicin)
Completed
- Acute Myeloid Leukemia
- Midostaurin
- +2 more
-
Innsbruck, Austria
- +54 more
Jun 3, 2020